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Background: Medicinal plants represent an important opportunity to rural communities in Africa, as a source of
affordable medicine and as a source of income. Increased patient awareness about safe usage is important as well
as more training with regards to traditional medicine. The aim of this study was to evaluate the ethnomedicinal
prowess of some indigenous South African plants commonly used in Eastern Cape Province of South Africa for the
treatment of skin and respiratory tract infections, HIV and their toxicity potential.
Methods: Cassine transvaalensis, Vangueria infausta, Croton gratissimus and Vitex ferruginea were tested for
antibacterial activities against Staphylococcus aureus and Staphylococcus epidermidis using Kirby-Bauer disk diffusion
and minimum inhibition concentration (MIC). Cytotoxic and anti-HIV-1 activities of plants were tested using MTT
Assay (3- (Dimethylthiozole-2-yl-2,5-diphenyltetrazolium bromide)) and anti- HIV-1iib assay. In search of bioactive
lead compounds, Cassine transvaalensis which was found to be the most active plant extract against the two
Staphylocoous bacteria was subjected to various chromatographic. Thin layer chromatography, Column chromatography
and Nuclear Magnetic Resonance (NMR), (1H-1H, 13C-13C, in DMSO_d6, Bruker 600 MHz) were used to isolate and
characterize 3-Oxo-28-hydroxylbetuli-20(29)-ene and 3,28-dihydroxylbetuli-20(29)-ene bioactive compounds from
C. transvaalensis.
Results: The four plants studied exhibited bioactive properties against the test isolates. The zones of inhibition ranged
between 16 mm to 31 mm for multi-drug resistant staphylococci species. MIC values varied between 0.6 and
0.02 μg/ml. C. gratissimus and C. transvaalensis exhibited the abilities to inhibit HIV-1iib. Two bioactive
compounds were isolated from C. transvaalensis.
Conclusion: Data from this study reveals the use of these plant by traditional healers in the Eastern Cape.
Furthermore, C. transvaalensis and C. gratissimus were found to be more active as against HIV-1iib. While C. transvaalensis
was most active against the two Staphylococcus bacteria.
Keywords: Staphylococci, Medicinal plant, Cytotoxic, Disk diffusion, Bioactive* Correspondence: aoyedeji@gmail.com
2Department of Chemistry and Chemical Technology, Walter Sisulu
University, Private Bag X1, Mthatha 5099, South Africa
Full list of author information is available at the end of the article
© 2014 Mthethwa et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Mthethwa et al. BMC Complementary and Alternative Medicine 2014, 14:512 Page 2 of 9
http://www.biomedcentral.com/1472-6882/14/512Background
Plants have been used as medicine to manage both ani-
mals and humans’ health throughout history, and studies
have shown that wild animals eat certain plants to treat
themselves from certain ailments [1-3]. In all the conti-
nents of the world, medicinal plants are consumed by
humans for management of health related issues, al-
though the practices and mode of uses may differ from
country to country and from tribe to tribe [4].
Most Africans still depend on and prefer traditional
medicine for the management of their health, just be-
cause of the fact that traditional medicine is affordably
cheap, available and accessible, also because of the folk-
loric beliefs that traditional herbal medicine has no side
effects [5]. Change in life style and behaviour have con-
tributed to the loss of knowledge concerning medicinal
plants. For many years people have used ingredients de-
rived from plants to treat various illnesses.
C. gratissimus Burchell is a shrub that may grow up to
10 metres in height. It is a slender tree with fine droop-
ing foliage and a crown which spread in a V-shape with
drooping terminal branches [6]. The upper surface of
the leaves is dark-green and shiny without hairs, while
the under surface is covered with scales resulting in sil-
very colour. It is found over a wide range of altitudes in
a variety of wood land type, often associated with rocky
outcrops [6]. The bark powder is used to treat bleeding
gums [7]. Milk infusions of the bark are used as purga-
tives for stomach disorders [6,7]. In Botswana, the leaves
are used for treating coughs [6,7], while Zimbabweans,
use the roots infusions for healing abdominal pains [7].
C. transvaalensisis Burth- Davy is a densely branched,
untidy tree with a roundish canopy [8]. The bark and
branches of the younger trees are light in color with
fairly smooth while the older branches and stem are dar-
ker with rougher patches. The leaves on the older trees
are light green in color and are arranged in groups on
very short twigs coming off the branches at right angles
[8,9]. The bark of the tree is used for tanning and to
make tea. It is said to be an excellent treatment for
stomach problems. It is also used as an enema for stom-
ach ache and fever and to treat diarrhoea. The leaves are
chewed and juice swallowed for sore throat [9].
V. infausta Burch is a small tree that varies in height
from 3–7 m, depending on the habitat [9]. It can be sin-
gle or multi-stemmed, but usually the latter. The bark
is greyish to yellowish brown, smooth and peeling in
irregular small strips [6]. The branchlets are covered
with short, woolly hairs, especially when young [6,9].
An infusion of leaves and roots is used to treat ring-
worms, toothache, malaria and chest ailments like
pneumonia [10].
V. ferruginea Schumach & Thonn is a shrub which
grows in bush veld thicket and sand forest usually on deepsand [9]. Leaves are aromatic, slender and elongated, may
be narrowly ovate or elliptic, with the upper surface
smooth or slightly hairy on veins and rusty velvety below
[9]. The decoction of V. ferrugenea is known to be used
traditionally for treating coughs, chest pains and stomach
disorders [9].
The uncensored uses of anti-infective agents have re-
sulted in emergence of drug resistant bacteria, fungi and
viruses [11], with staphylococcus species taking the leads
of most reported emerging resistant bacterial specie.
Among the staphylococci, Staphylococcus aureus and
Staphylococcus epidermidis have great pathogenic poten-
tial, with myriads of literatures citing the opportunistic
virtues of these two strains in causing difficult to treat
systemic infections [11-13]. Moreover S. epidermidis is
well known for its potential to be opportunistic and to
greatly initiate infections in immune-compromised pa-
tients [13].
S. aureus and S. epidermidis infections are treated with
antibiotics; penicillins being the drug of choice. The per-
centage of staphylococcal strains exhibiting wide-
spectrum resistance to antibiotics have become increas-
ingly rampant, posing a threat for effective antimicrobial
therapy [14,15].
In a bid to find alternatives treatment of resistant Sta-
phylococccus infections; this study was carried out to
evaluate the antibacterial and anti-HIV-1iib activities of
four medicinal plants commonly used in Eastern Cape
Province, South Africa for the treatment of skin and re-
spiratory tract infections. Furthermore, the most active
of all was subjected to bioactive isolation in a search for
bioactive compounds that could be used in drug formu-
lation. This study also intends to shed more light on the
hidden biological potentials of the four candidate plants




1. Scientific name: Croton gratissimus Burch.
Family: Euphorbiaceae
Xhosa name: Mahlabekufeni
Common name: Lavender croton




Common name: bushveld saffron (Eng.)




Common name: wildmedlar (Eng)
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Common name: Plum finger leaf
Vangueria infausta (roots), Cassine transvaalensis
(bark), Croton grattisimus (leaves) and Vitex ferruginea
(leaves) were collected near flagstaff in the Eastern
Cape, South Africa and identified by Immelman KL in
Botany Department of Walter Sisulu University. Voucher
specimens were deposited in the herbarium of Botany De-
partment, Walter Sisulu University, Eastern Cape, South
Africa with voucher specimen numbers MNS 001, MNS
002, MNS 004, and MNS 003 for V. infausta, C. trans-
vaalensis, C. grattisimus and V. ferruginea respectively.
Plant material was air dried, ground and extracted with
distilled methanol. Plants material (1.5 kg) was soaked
and placed on the shaker for two days, filtered with
Whatmanns No1 filter paper then concentrated using
rotary evaporator [16].
Bacterial inoculum and magi cells culture preparation
One hundred and eighty three multidrug resistant hos-
pital isolates of staphylococcus strains: S. aureus (100),
S. epidermidis (83) were used in this study. American
Type Culture Collection (ATCC) strains of S. aureus
(25923) and S. epidermidis (12228) were used as con-
trols. S. aureus and S. epidermidis strains were grown on
Mueller Hinton broth (Oxoid) medium at 37°C. The cul-
ture was then adjusted to 0.5 McFarland standard.
MAGI CCR5 cell lines purchased from ATCC, Manas-
sas, VA 20108, USA were used for cytotoxic screening of
medicinal plant extracts. Trypsin was added to magi
cells and incubated for 5 minutes to detach them from
each other. The cells were then diluted with Dulbecco’s
modified eagle medium (DMEM) with L-Glutamin and
Phenol red media. Cell lines were cultured in advanced
Modified Eagle’s Medium with 10% 5mML-glutamine
(GibcoBRL) and grown at 37°C in a 5% CO2 humidified
incubator (Thermo Fisher Scientific, Wakenyaku Co.
Ltd, Japan). Cells were sub culture devery 48 hours until
confluent growth was observed.
Antibacterial screening
Kirby-bauer disk diffusion
One gram of each plant extract was reconstituted in 10%
Dimethyl sulphoxide (DMSO) to get a concentration of
0.1 g/ml. This was further diluted to 0.05 g/ml. C. trans-
vaalensis (bark),V. infausta (roots), C. grattisimus (leaves)
and V. ferruginea (leaves) extracts were tested against dif-
ferent strains of S. aureus and S. epidermidis. Fifteen mi-
croliters (15 μl) of plant extract was suspended on a 6 mm
paper disks and placed on Mueller-Hinton agar plateinoculated with S. aureus or S. epidermidis. The plates
were then incubated at 37°C for 18 hours. The antibacter-
ial activities were evaluated by measuring inhibition zone
diameters [17]. These assay was done in triplicates.
Minimum Inhibitory Concentration (MICs) assay
A micro-dilution technique described by [18] which uses
96-well microtitre plate was used for MICs. The micro-
bial cultures were diluted in fresh Mueller-Hinton broth
to a 0.5 McFarland standard. Fifty microliters of Mueller
Hinton broth was added to all wells, followed by 50 μl
broth culture and 50 μl of plant extracts dissolved in
DMSO. Plant extracts were diluted from the first row of
the micro-titre plate. Cloxacillin was used as positive con-
trol and DMSO as negative control. Micro plates were
covered with lids and incubated at 37°C overnight. Fifty
microliters of 0.2% solution of P-iodonitrotetrazolium vio-
let (Sigma) (0.2 mg/ml) reagent was used to indicate the
presence of uninhibited bacterial growth (purple colour)
or inhibition (colourless) of bacterial growth in each well.
The lowest concentration of crude plant extract that
inhibited bacterial growth was taken as the MIC [18].
These assay was done in triplicates.
Cytotoxic and anti- HIV-1 screening of medicinal plants
MTT assay 3- (Dimethylthiozole-2-yl-2, 5-
diphenyltetrazolium bromide)
MTT assay was performed to determine cytotoxicity of
plant extracts as first described by Mosmann [19] with
modifications suggested by Akhir [20]. MAGI CCR5
cells were seeded into two 96 well plates with 104 cells/
well in 100 μl of DMEM supplemented with 10% foetus
bovine serum (FBS). Eleven microliters (5 mg/ml) of
plant extract was added. After 48 h cells were observed
and supernatant from each well discarded. The MTT re-
agent (10 μl) was added into each well. Plates were incu-
bated at 37°C for 4 h, after which 100 μl MTT-stop
solution containing sodium dodecyl sulphate was added
into each well and plates optical density was observed at
a wave length of 570 nm then the 50% cytotoxic concen-
tration (CC50) was determined. A toxic substance, ber-
berine was used as a positive control [21].
Anti-HIV-1IIIB assay
Anti-HIV-1 assay was conducted according to Kanamoto
[22]. The inhibitory effects of the plant extracts on HIV-
1iib replication were estimated by the levels of inhibition
of virus induced cytopathic effects (CPE) in MT-4 cells.
MAGI CCR5 cells in Dulbecco’s modified Eagle medium
containing 10%FBS and plant extracts were cultured in
96 well culture plate for 24 hrs. One hundred microliters
of the HIV-1virus was added into wells. After two days the
cells were fixed with 100 μl of phosphate buffered saline
(PBS) containing 1% formaldehyde and 0.2% gluteraldehyde
Table 1 Average zones of inhibition exhibited by the









S. aureus S. epidermidis
C. transvaalensis 23 31 23 25
V. infausta 23 24 20 23
C. gratissimus 22 27 20 25
V. ferruginea 16 19 17 20
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three times with PBS and incubated for 1 h at 37°C with
100 μl of staining solution (4 mM potassium ferrocyanide,
4 mM potassium ferricyanide, 2 mM MgCl2, and 400 μg of
5-bromo-4-chloro-3-indolyl-β-D-galactoside per ml). The
reaction was stopped by washing twice the stain off with
PBS and finally100 μl of PBS was added into the wells. Cells
infected with HIV, the integrated HIV long terminal repeat
(LTR) β-gal reporter gene was expressed and the cells
turned blue on staining. Blue cells were counted under light
microscope. The 50% effective concentration (EC50) and se-
lectivity index (SI = CC50/EC50) were determined. The anti-
HIV-1 activity of the plant extract was represented as the
percent inhibition of the blue cell expression and was calcu-
lated as follows:
½1‐ blue cell counts with test plant extract=ð
blue cell counts without plant extractÞ  100
Infection with virus (1:5 v/v of virus/media) to obtain
a 200X TCID (Tissue culture infective dose) was consid-
ered adequate for this study. All tests and analyses were
run in triplicate.
Isolation of active compounds
Sequential solvent extraction
Hexane, dichloromethane (DCM), ethyl acetate, metha-
nol were used in the sequential extraction respectively.
The extracts were filtered using Whatmanns no1 filter
paper, then the solvents were removed by vacuum distil-
lation in a Buchi rotary evaporator. The extracts were
concentrated such that almost all the extracting solvent
was removed then transferred to pre-weighed beakersTable 2 Minimum inhibition concentration (MIC) of plant extr
MIC
(μg/ml)
C. transvaalnsis (%) V. infausta (%)
S. aur S.epi S. aur S.ep
0.6 4 17 6 6
0.2 22 31 48 28
0.06 12 6 14 n.a
0.02 6 2 3 n.a
Table legend: S. aur = S. aureus; S. epi = S. epidermidis; ND = Not Determined; n.a = Noand allowed to dry completely in the fume cupboard.
The beakers were weighed again in order to determine
the actual weight of the extracted material.
Thin layer chromatography TLC
The dried plant extracts were re-dissolved in methanol.
Each plate was spotted with two plant extracts using the
capillary tube. The separation was carried out at room
temperature on a 10 × 10 cm silica gel plates (ALU-
GRAM® SIL G fűr die DC). The chromatograms were
run in small glass tanks with the running solvent of hex-
ane: ethyl acetate (80:20). The plates were dried at room
temperature and developed in crystal iodine.
Bio-autographic assay
Methanol plant extracts were spotted on the TLC plate
(ALUGRAM® SIL G fűr die DC) using capillary tube and
separated in 80:20 (hexane: ethylacetate) as it was found to
be the best separating solvent for Cassine transvaalensis.
The plate was allowed to dry at room temperature. The
test culture was sprayed on the TLC plate and incubated
at 37°C overnight. The following day the plates were
sprayed with iodonitrotetrazolium (INT) (0.2 mg/ml) [23].
The locations of the active compounds were numerically
presented by calculating the retention factor (Rf).
Column chromatography for separating plant compounds
A 400 ml glass column was packed with 60 g of fine sil-
ica gel (1.10757.1000). Two grams of plant extract to be
run in the column was mixed with silica gel and ground
to fine powder, this was then poured on top of the sand
layer. 200 ml of 100% hexane was first used to run the
column, followed by 200 ml of hexane: ethyl acetate
(95:5), the polarity was gradually increased with ethyl
acetate until the ratios reached 50:50. Twenty millilitres
of fractions were collected in each beaker, and spotted
on the TLC plate. Hexane: ethyl acetate (80:20) was used
as a mobile phase to run TLC. Developing spots were
observed under a 250 nm wavelength UV light and in
crystal iodine vapour. The fractions with the same bands
appearing on the TLC plate were combined. The Rf
values were calculated and compared to those found in
the bioassay plates for the active compounds.acts against S. aureus and S. epidermidis
C. gratissimus (%) V. ferruginea (%)
i S. aur S. epi S. aur S.epi
4 33 ND ND
5 17 ND ND
n.a n.a ND ND
n.a n.a ND ND
t applicable.
Table 3 Anti-HIV and cytotoxic activities determined by
MTT and MAGI assays
Plant extract (mg/ml) EC50 (μg/ml) CC50 (μg/ml) SI
C. gratissimus 9.6 100 10.4
C. transvaalensis 3.5 200 57.1
V. infausta n.a 100 n.a
V. ferrugenea n.a 130 n.a
Berberine n.a 27 n.a
Table legend: n.a = Not applicable, SI = Selectivity index.
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in DMSO_d6, Bruker 600 MHz) technique was used to
confirm the structure of compounds. Chemical shifts
were expressed in δ (ppm).
Results
Antibacterial susceptibility against medicinal plants
The four plant extracts used in this study demonstrates
good to moderate bioactivities as confirmed by different
assays in the study. The plant extracts (0.1 g/ml) exhibited
antibacterial activities against multidrug resistant S. aureus
and S. epidermidis strains isolated from patients (Table 1).
The zones of inhibition ranged between 16 mm to 31 mm
for multi-drug resistant staphylococci species. C. transvaa-
lens is exhibited the average of 31 mm zone of inhibition
against S. epidermidis and 23 mm against S. aureus. V. fer-
ruginea seemed to have lower average zones of inhibition
against S. aureus (16 mm) and S. epidermidis (19 mm). It
was observed that the ATCC control strains of S. epider-
midis (12228) and S. aureus (25923) exhibited zones of in-
hibition ranging from 17 mm to 25 mm.
The minimum inhibition concentration (MIC) of the
crude extracts was also determined. MIC values varied
between 0.6 and 0.02 μg/ml (Table 2). C. transvaalensis
was observed to be the most bioactive plant extracts
which was able to inhibit 6% multi drug resistant strains
of S. aureus and 2% S. epidermidis from patients at a
minimum concentration of 0.02 μg/ml. C. gratissimus
inhibited 17% and 5% S. aureus and S. epidermidis mul-
tidrug resistant strains at a concentration of 0.2 (μg/ml).
MIC values of V. infausta were higher than the values
represented in Table 2.
Anti-HIV-1 and cytotoxic activities results
C. gratissimus and C. transvaalensis exhibited abilities to
inhibit HIV-1IIIB and displayed SI values >5 which are
considered significant. The evaluation of cytotoxic and
anti-HIV activities by MTT assay resulted in CC50 of
200 μg/ml,100 μg/ml, 100 μg/ml and 130 μg/ml for C.
transvaalensis, C. gratissimus, V. infausta and V. ferru-
genea respectively which were higher than that of the
positive control (berberine).The EC50 of C. gratissimus
and C. transvaalensis was estimated to be 9.6 μg/ml and3.5 μg/ml with selectivity indexes (SI) of 10.4 and 57.1
respectively indicating anti-HIV-1iib (Tables 3 and 4).
Thin layer chromatography and bio-autographic assay
results
The solvents that were found suitable for the isolation of
bio-active plant compounds were ethyl acetate: dichloro-
methane: methanol (55:5:40) using thin layer chromatog-
raphy. These solvents were used as the mobile phase in
the successful isolation of two compounds from C. trans-
vaalensis. The bio-autographic assay revealed clear zones
of inhibition with the Rf values of 0.3 and 0.5which corre-
sponded with Rf values of compounds that were targeted
in thin layer chromatography. The clear zones indicate
that these compounds are able to inhibit the growth of S.
aureus and S. epidermidis.
Compounds isolated from Cassine transvaalensis
Compound 1 and 2 were isolated from C. transvaalensis,
compound 1 was isolated as the white crystal powder at
80: 20 Hexane: Ethyl acetate ratio and found to be sol-
uble in Hexane and deuterated DMSO for NMR ana-
lysis. Compound 2 was isolated as a colourless powder
at a ratio of 55:5:40 Ethyl acetate:dichloromethane:metha-
nol in chloroform and CDCl3 was used for the NMR runs.
Structural elucidation of compound 1 and 2 was achieved
by comparing their NMR spectra data with those in litera-
ture (Table 4).
Compound 1: 3-Oxo-28-hydroxylbetuli-20(29)-ene
This was isolated as a white crystal powder. The 1H-
NMR spectrum pattern suggested a triterpenoid com-
pound. Analysis of the 13C-NMR spectra showed that it
is a C30 compound which further strengthen the class
of compound suggested. The presence of six tertiary
methyl (CH3), and one carbonyl carbon signals in the
proton and carbon 13 spectra respectively; twelve
methylene (CH2) signals, five methane (CH) and seven
quaternary carbons (C) from the carbon DEPT spectra
supported a pentacyclic tritepeniod sketal structure of a
betuilene. The presence of two olefinic protons at 4.7 to
4.8 which were attached to a carbon at 106.1 ppm sug-
gested a terminal CH2. The lack of a carboxylic carbon
at 178-183 ppm indicated that it was not a triterpenic acid,
but the carbon at 217.2 ppm suggested the presence of a
ketone functional group and thereby confirms the struc-
ture of compound 1 as 3-Oxo-28-hydroxylbetuli-20(29)-
ene with the aid of the 2D NMR (Figure 1). Furthermore,
literature data as shown in Tables 3 and 4 correlates with
our data and thereby confirms structure compound 1 as a
3-Oxo-28-hydroxylbetuli-20(29)-ene. 3-Oxo-28-hydroxyl-
betuli-20(29)-ene) was obtained by column chroma-
tography as a white powder, it was visible under the UV
light. NMR was used for characterization and structure
Table 4 1H-NMR and 13C-NMR data of compound 1 and 2 compared to literature
1H (600 MHz) 1Hlit 13C (600 MHz) 13Clit
CPD 1 CPD 2 CPD 1 CPD 1 CPD 2 CPD 1 [24] CPD 2 [24]
1 0.88(1H,t) 0.64(1H,s) 1.21(1H,t) 0.98(m) 39.4(t) 38.0 39.9 38.8
1.24(1H,t)
2 1.98(2H,m) 1.05(1H.m) 34.4(t) 27.4 34.1 27.2
3 - 4.26(1H,m) 1.83(1Hm) 217.2(s) 74.3 218.3 78.9
1.96(1Hm)
4 - 47.8(d) 38.7 47.2 38.9
5 0.68(t) 54.5(d) 56.5 54.5 55.3
6 1.40(m) 19.8(t) 18.4 19.8 18.3
1.6(m)
7 1.35(m) 34.2 36.9 34.3
1.41(m)
8 - 43.1(s) 39.8 42.4 40.9
9 1.68(m) 49.6 50.1 50.3 50.4
10 - 37.9 37.1 37.2
11 1.26(m) 21.4 22.5 21.5 20.9
1.42(m)
12 1.41(m) 26.2 25.8 25.2 25.3
1.52(m)
13 0.69(m) 37.6 33.3 37.0 37.3
14 - 47.0 44.1 47.8 42.7
15 1.41(m) 63.3 26.4 69.0 27.0
1.52(m)
16 1.33(m) 28.5 40.3 29.2
1.42(m)
17 - 48.6 47.9 47.8
18 1.77(dd) 50.9 48.8 48.8
19 3.01(dt) 48.4 47.2 47.8
20 - 155.5 150.5 149.9 150.6
21 1.41(m) 29.0 30.0 29.8
1.51(m)
22 1.35(m) 33.5 31.5 33.9 34.0
1.41(m)
23 0.84(3H,s) 0.85(3H,s) 0.81(s) 26.9 27.5 26.6 28.0
24 0.86(3H,s) 0.86(3H,s) 0.83(s) 21.4 16.2 21.0 15.4
25 0.94(3H,s) 0.90(3H,s) 0.93(s) 14.1 18.2 16.1 16.1
26 0.99(3H,) 0.97(3H,s) 0.99(s) 16.2 16.3 16.3 16.0
27 0.78(3H,s) 0.76(3H,s) 1.02(s) 5.5 16.1 8.1 14.8
28 3.8(1H,s,OH) 3.58 (1H, s,OH) 62.5 63.0 61.5 60.2
29 4.8(1H,d) 4.7(1H,s) 4.85(1,m) 4.72-4.75 (1,m) 4.74(brs) 4.65(br,s) 106.1(t) 106.0 110.0 109.6
30 1.64 (s) 1.63(s) 1.69(s) 18.1(q) 20.9 19.1 19.1
Table legend: CPD1 = Compound 1; CPD 2 = Compound 2; 1Hlit = From literature; 13Clit = From literature [24-26].


























Figure 1 Legend: Elucidated structure of compound 1 (3 –Oxo-28-hydroxylbetuli-20(29)-ene) [24;26]. δc(DMSO_d6): 14.93; 16.23; 18.18;
19.80; 21.43; 26.95; 31.82; 34.41; 35.71; 43.18; 47.08; 49.68; 54.55; 63.31; 106.18; 155.53; 217.23. δH(DMSO_d6): 0.76; 0.86; 0.94; 0.99; 1.03; 1.24; 1.35;
1.35; 1.38; 1.41; 1.61; 1.64; 1.80; 1.98; 2.21; 2.23; 2.24; 2.41; 2.50; 3.90; 4.78; 4.87.
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Molecular weight of 440.
Compound 2: 3,28-dihydroxylbetuli-20(29)-ene
This was isolated as a colourless crystal powder. The
1H-NMR spectrum had the characteristic triterpenoid
patterns with clusters of peaks around values 0.50 to
2.50 and similar spectra pattern as compound 1 sug-
gested a triterpenoid compound. Analysis of the 13C-
NMR spectra showed that it is a C30 compound which
further strengthen the class of compound suggested.
The 1H-NMR spectrum showed peaks at 3.58 (H-28);
4.70 and 4.80 (H-29) which is a hydroxyl group at pos-
ition 28 and olefinic protons at position 29 which are
similar to the proton chart of compound 1. There is also
another peak at 4.20 which represent OH in the
chemical shift chart. This suggested the present of an
OH group at position 3 since there ketone carbon was
absent.
The presence of six tertiary methyl (CH3), and one
carbonyl carbon signals in the proton and carbon 13 spec-
tra respectively; twelve methylene (CH2) signals, five
methine (CH) and seven quaternary carbons (C) from the
carbon DEPT spectra supported a pentacyclic tritepeniod
sketal structure of a betuilene. The presence of two oleni-
fic protons at d 4.70 to 4.80 which were attached to a car-
bon at 106.1 ppm suggested a terminal CH2 (HSQC). The
absence of a carboxylic carbon at 178-183 ppm indicated
that it was not a triterpenic acid, and at 217.2 ppm sug-
gested that the presence of a ketone functional group
which was noticed in compound 1 was completely ab-
sence in compound 2 (Figure 2). Compound 2 was there-
fore elucidated to be 3,28-dihydroxylbetuli-20(29)-ene.
Compound 2 was isolated as colourless powder duringcolumn chromatography. The elucidated structure was sup-
ported by the NMR spectra which showed double bond at
position 29, dihydroxyl group in position 28 and 3.
Discussion
C. transvaalensis and V. infausta showed good antibac-
terial activity against multidrug resistantS. aureus and S.
epidermidis. Forty five percent and 58% of clinical
strains of multidrug resistant S. aureus and S. epidermi-
dis respectively were susceptible to C. transvaalensis. V.
infausta inhibited 70% (S. aureus) and 36% (S. epidermi-
dis). C. transvaalensis have been reported to have vari-
ous biological activities [27-29]. Shai et al. [30] tested
and confirmed antibacterial activity of V. infausta ex-
tracts against several bacterial species including Gram
positive bacteria with MIC values of 0.2 mg/ml. It was
also observed that C. gratissimus also had good activity
against S. epidermidis because it was able to inhibit 58%
of the clinical isolates. HIV is one of the most problem-
atic Public Health concerns worldwide as it contributes
as front liner cause of deaths among African population.
The observed anti-HIV activity as well as minimal tox-
icity of these studied plants offer promise for their phy-
totherapeu1tic application in management of HIV/AIDS.
In this study C. transvaalensis and C. gratissimus were
able to inhibit the HIV infection growth.
The cellular cytotoxicity of extracts was screened in
cells representative of the immune system especially
those known to be the host cells for HIV infection.
Therefore MT-4 cells were selected for both anti-HIV
activity (EC50) using whole virus and cellular cytotoxicity
screening (CC50). Out of four plant extracts evaluated
for anti-HIV and cytotoxicity Croton grattisimus and





























Figure 2 Legend: elucidated structure of compound 2 (3,28-dihydroxylbetuli-20(29)-ene) [24-26]. δc(DMSO_d6): 14.93; 16.23; 18.18; 19.80;
21.43; 26.95; 31.82; 34.41; 35.71; 43.18; 47.08; 49.68; 54.55; 63.31; 106.18; 155.53; 217.23. δH(DMSO_d6): 0.64; 0.76; 0.85; 0.86; 0.90; 0.94; 0.97;1.23;
1.33; 1.42; 1.43; 1.63; 1.97; 2.21; 2.21; 2.49; 2.95; 2.96; 2.97; 3.58; 4.26; 4.72; 4.75; 4.85.
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40 μg/ml which was greater than that of the berberine
used as a positive control.
Compounds isolated from C. transavaalensis were
found to be triterpenoids because they have 30 carbons
and five rings. These compounds were identified by
comparison of their spectroscopic data with those re-
ported in literature [26] (Tables 3 and 4). Compound
1 has molecular formula of C30H48O2. The
13C-NMR
spectra of compound 1 showed signal for CH3, CH2,
CH, HC = CH, C = O and quaternary C. 1H-NMR was
used to detected the number of hydrogen atoms pres-
ence in the unknown compound which was white
powder. The compounds isolated from C. transvaa-
lensis were proven to be active against S. aureus and
S. epidermidis because of the clear zone around them
on the bio autographic assay. The Rf value of com-
pounds isolated corresponded to that of the active
compounds in the bio autographic assay. Compound
2 has a hydroxyl group at C-3 position in its struc-
ture which is a secondary hydroxyl group and a pri-
mary hydroxyl group at position C-28. The isolated
triterpenes are also known to have anti-inflammatory
and anti-HIV-1 activity [31]. The 1H-NMR spectrum
showed peaks at 3.8 (H-28); 4.7 and 4.8 (H-29) which
was a double bond which corresponded to the hydro-
gen position in the chemical shift chart. The six
peaks at position 1.0 to 0.7 corresponded to the CH3
position in the chemical shift chart. The 13C-NMR
detected the carbon atoms in compounds and showed
the peak in position 217.2 was a ketone. The other
peaks were found at position 15.5 (C20) and 106.18
(C28). The
1H-13C HSQC showed the correspondingatoms of hydrogen and carbon. It is seen that the two
peaks at H-29 correspond to C-29 and also H-28 to
C-28.
Tables 3 and 4 shows the 1H-NMR and 13C-NMR data
of compound 1 and 2 which were assigned with the help
of HSQC, COSY, HMBC and NOESY. Further compar-
ism with literature. Literature has confirmed that these
compounds have been isolated before from other plant
sources hence the comparison in the above table.
Conclusion
Data from this study supports the traditional use of
studied plants in the treatment of skin ailments caused
by staphylococci species. The results from this study also
suggests that further screening of South African plants
used in traditional medicine is warranted. C. gratissimus,
C. transvaalensis and V. infausta can be considered as
potential sources of antimicrobial agents against the test
pathogens.
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